NCT02741219

A Multicenter Study: Dexmedetomidine Combined With Sufentanil for Patient Controlled Intravenous Analgesia After Caesarean Section

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 225 (actual)
• Sponsor: Obstetrics & Gynecology Hospital of Fudan University · Academic / Other
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this multicenter study is to evaluate the effectiveness and safety of dexmedetomidine combined with sufentanil for patient-controlled analgesia after caesarean section

Conditions

• Postoperative Pain

Interventions

Type	Name	Description
DRUG	Normal saline	Control Group receives normal saline bolus after delivery
DRUG	Dexmedetomidine	Dex Group receives dexmedetomidine bolus 0.5mcg/kg after delivery
DRUG	Sufentanil	sufentanil PCA after surgery
DRUG	Sufentanil and dexmedetomidine	sufentanil combined with dexmedetomidine PCA after surgery

Timeline

• Start date: 2015-11-01
• Primary completion: 2016-01-01
• Completion: 2016-01-01
• First posted: 2016-04-18
• Last updated: 2021-05-07

Locations

1 site across 1 country: China